TR-FRET biochemical assays for detecting posttranslational modifications of p53

Jeanne M Dudek1, Robert A Horton

  • 1Invitrogen, Part of Life Technologies, Madison, WI 53719, USA.

Insights

Researchers developed a novel assay to measure key modifications of the p53 tumor suppressor protein, aiding in the discovery of cancer-fighting drugs. This high-throughput method analyzes phosphorylation, acetylation, and ubiquitination of p53.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • The p53 tumor suppressor protein is crucial in preventing cancer by controlling cell cycle, DNA repair, and apoptosis.
  • Cellular pathways regulate p53 activity through posttranslational modifications (PTMs).
  • Understanding p53 PTMs is vital for cancer therapy development.

Purpose of the Study:

  • To develop a high-throughput assay for analyzing critical p53 posttranslational modifications.
  • To enable the simultaneous measurement of phosphorylation, acetylation, and ubiquitination using a single substrate.
  • To facilitate the discovery of inhibitors targeting p53 regulatory enzymes.

Main Methods:

  • Development of a time-resolved fluorescence resonance energy transfer (TR-FRET)-based assay.
  • Utilized full-length p53 protein fused with GFP (GFP-p53) as a versatile substrate.
  • Adapted the assay to measure deacetylation for inhibitor screening.

Main Results:

  • Successfully measured three key p53 PTMs (phosphorylation, acetylation, ubiquitination) with a single GFP-p53 substrate.
  • Demonstrated the assay's adaptability for deacetylation analysis.
  • Established a flexible platform for dissecting p53 regulatory mechanisms.

Conclusions:

  • The developed TR-FRET assay provides a robust tool for studying p53 PTMs.
  • This assay facilitates the discovery of targeted inhibitors for cancer therapy.
  • The platform enhances our understanding of p53's complex regulatory network.

Related Concept Videos